Institutional Fund
Aju Ib Investment Co., Ltd.
Seoul, South KoreaCIK 17100656 filings on record
Portfolio Value
$30.52M
Q1 2026
Holdings
6
Reported positions
New Buys
2
Opened this quarter
QoQ Change
+33.9%
from $22.79M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Arcellx Inc84.1%
- Kymera Therapeutics Inc5.4%
- Seer Inc5.1%
- Rallybio Corp2.8%
- Sutro Biopharma Inc1.4%
- Xilio Therapeutics Inc1.3%
Portfolio Holdings
6 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Arcellx Inc | 223.5K | $25.66M | 84.1% | 0 | Held |
| 2 | Kymera Therapeutics Inc | 19.6K | $1.64M | 5.4% | 0 | Held |
| 3 | Seer Inc | 816.4K | $1.54M | 5.1% | 0 | Held |
| 4 | Rallybio Corp | 94.3K | $846.2K | 2.8% | +94.3K | New |
| 5 | Sutro Biopharma Inc | 17.5K | $435.9K | 1.4% | 0 | Held |
| 6 | Xilio Therapeutics Inc | 47.7K | $401.1K | 1.3% | +47.7K | New |